Asakura-Kinoshita, M.; Masuda, T.; Oka, K.; Ohara, K.; Miura, M.; Morinari, M.; Misawa, K.; Miyazawa, Y.; Akimoto, T.; Shimada, K.;
et al. Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction. Diagnostics 2024, 14, 1194.
https://doi.org/10.3390/diagnostics14111194
AMA Style
Asakura-Kinoshita M, Masuda T, Oka K, Ohara K, Miura M, Morinari M, Misawa K, Miyazawa Y, Akimoto T, Shimada K,
et al. Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction. Diagnostics. 2024; 14(11):1194.
https://doi.org/10.3390/diagnostics14111194
Chicago/Turabian Style
Asakura-Kinoshita, Maki, Takahiro Masuda, Kentaro Oka, Ken Ohara, Marina Miura, Masato Morinari, Kyohei Misawa, Yasuharu Miyazawa, Tetsu Akimoto, Kazuyuki Shimada,
and et al. 2024. "Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction" Diagnostics 14, no. 11: 1194.
https://doi.org/10.3390/diagnostics14111194
APA Style
Asakura-Kinoshita, M., Masuda, T., Oka, K., Ohara, K., Miura, M., Morinari, M., Misawa, K., Miyazawa, Y., Akimoto, T., Shimada, K., & Nagata, D.
(2024). Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction. Diagnostics, 14(11), 1194.
https://doi.org/10.3390/diagnostics14111194
